Old Web
English
Sign In
Acemap
>
authorDetail
>
Helen Martino
Helen Martino
Cantuzumab mertansine
Immunoconjugate
Immunology
Medicine
Pharmacokinetics
3
Papers
226
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid Tumors
2004
Clinical Cancer Research
Paul R. Helft
Richard L. Schilsky
Frank J. Hoke
D. D. Williams
Hedy L. Kindler
Evie Sprague
Mark DeWitte
Helen Martino
John Erickson
Lini Pandite
Mark Russo
John M. Lambert
Maria Howard
Mark J. Ratain
Show All
Source
Cite
Save
Citations (45)
Cantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study
2003
Journal of Clinical Oncology
Anthony W. Tolcher
Leonel Ochoa
Lisa A. Hammond
Amita Patnaik
Tam Edwards
Chris H. Takimoto
Lon Smith
Johann S. de Bono
Garry Schwartz
Theresa Mays
Zdenka L. Jonak
Randall Johnson
Mark DeWitte
Helen Martino
Charlene Audette
Kate Maes
Ravi V. J. Chari
John M. Lambert
Eric K. Rowinsky
Show All
Source
Cite
Save
Citations (181)
Cantuzumab M ertansine, a M aytansinoid I mmunoconjugate Directed t o t he C anAg A ntigen: A P hase I , P harmacokinetic, and B iologic C orrelative S tudy
2003
Anthony W. Tolcher
Leonel Ochoa
Lisa A. Hammond
Amita Patnaik
Tam Edwards
Chris Takimoto
Lon Smith
Johann S de Bono
Garry Schwartz
Theresa Mays
Zdenka Ludmila Jonak
Randall K. Johnson
Mark DeWitte
Helen Martino
Charlene Audette
Kate Maes
John M. Lambert
Eric K. Rowinsky
Show All
Source
Cite
Save
Citations (0)
1